Download PDF
Planta Med 2013; 79(15): 1421-1428
DOI: 10.1055/s-0033-1350699
Pharmacokinetic Investigations
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Characterization of in Vitro ADME Properties of Diosgenin and Dioscin from Dioscorea villosa

Vamshi K. Manda
1   National Center for Natural Products Research, The University of Mississippi, University, MS, USA
,
Bharathi Avula
1   National Center for Natural Products Research, The University of Mississippi, University, MS, USA
,
Zulfiqar Ali
1   National Center for Natural Products Research, The University of Mississippi, University, MS, USA
,
Yan-Hong Wong
1   National Center for Natural Products Research, The University of Mississippi, University, MS, USA
,
Troy J. Smillie
1   National Center for Natural Products Research, The University of Mississippi, University, MS, USA
,
Ikhlas A. Khan
1   National Center for Natural Products Research, The University of Mississippi, University, MS, USA
2   Department of Pharmacognosy, School of Pharmacy, The University of Mississippi, University, MS, USA
,
Shabana I. Khan
1   National Center for Natural Products Research, The University of Mississippi, University, MS, USA
2   Department of Pharmacognosy, School of Pharmacy, The University of Mississippi, University, MS, USA
› Author Affiliations
Further Information

Publication History

received 08 April 2013
revised 05 July 2013

accepted 08 July 2013

Publication Date:
22 August 2013 (online)

    Permissions and Reprints

Abstract

Dioscorea villosa (wild yam) is native to North America and has been widely used as a natural alternative for estrogen replacement therapy to improve womenʼs health as well as to treat inflammation, muscle spasm, and asthma. Diosgenin and dioscin (glycoside form of diosgenin) are reported to be the pharmacologically active compounds. Despite the reports of significant pharmacological properties of dioscin and diosgenin in conditions related to inflammation, cancer, diabetes, and gastrointestinal ailments, no reports are available on ADME properties of these compounds. This study was carried out to determine ADME properties of diosgenin and dioscin and their effects on major drug metabolizing enzymes (CYP 3A4, 2D6, 2C9, and 1A2). The stability was determined in simulated gastric and intestinal fluids (SGF, pH 1.2 and SIF, pH 6.8), and intestinal transport was evaluated in Caco-2 model. Phase I and phase II metabolic stability was determined in human liver microsomes and S9 fractions, respectively. Quantitative analysis of dioscin and diosgenin was performed by UPLC-MS system. Dioscin degraded up to 28.3 % in SGF and 12.4 % in SIF, which could be accounted for by its conversion to diosgenin (24.2 %. in SGF and 2.4 % in SIF). The depletion of diosgenin in SGF and SIF was < 10 %. Diosgenin was stable in HLM but disappeared in S9 fraction with a half-life of 11.3 min. In contrast, dioscin was stable in both HLM and S9 fractions. Dioscin showed higher permeability across Caco-2 monolayer with no significant efflux, while diosgenin was subjected to efflux mediated by P-glycoprotein. Diosgenin and dioscin inhibited CYP3A4 with IC50 values of 17 and 33 µM, respectively, while other CYP enzymes were not affected. In conclusion, dioscin showed better intestinal permeability. Conversion of dioscin to diosgenin was observed in both gastric and intestinal fluids. No phase I metabolism was detected for both compounds. The disappearance of diosgenin in S9 fraction indicated phase II metabolism.

Key words

Dioscorea villosa - Dioscoreaceae - diosgenin - dioscin - Caco-2 - metabolic stability - CYP inhibition - intestinal transport

Supporting Information

 

  • References

  • 1 Komesaroff PA, Black CV, Cable V, Sudhir K. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 2001; 4: 144-150
    CrossrefPubMedGoogle Scholar
  • 2 Al-Matubsi HY, Nasrat NA, Oriquat GA, Abu-Samak M, Al-Mzain KA, Salim M. The hypocholesterolemic and antioxidative effect of dietary diosgenin and chromium chloride supplementation on high-cholesterol fed Japanese quails. Pak J Biol Sci 2011; 14: 425-432
    CrossrefPubMedGoogle Scholar
  • 3 Das S, Dey KK, Dey G, Pal I, Majumder A, Maitichoudhury S, Kundu SC, Mandal M. Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma. PLoS One 2012; 7: e46641
    CrossrefPubMedGoogle Scholar
  • 4 Kim DS, Jeon BK, Lee YE, Woo WH, Mun YJ. Diosgenin induces apoptosis in HepG2 cells through generation of reactive oxygen species and mitochondrial pathway. Evid Based Complement Alternat Med 2012; 2012: 981675
    PubMedGoogle Scholar
  • 5 Jan TR, Wey SP, Kuan CC, Liao MH, Wu HY. Diosgenin, a steroidal sapogenin, enhances antigen-specific IgG2a and interferon-gamma expression in ovalbumin-sensitized BALB/c mice. Planta Med 2007; 73: 421-426
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Sautour M, Mitaine-Offer AC, Miyamoto T, Dongmo A, Lacaille-Dubois MA. Antifungal steroid saponins from Dioscorea cayenensis . Planta Med 2004; 70: 90-92
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Kim YS, Kim EA, Park KG, Lee SJ, Kim MS, Sohn HY, Lee TJ. Dioscin sensitizes cells to TRAIL-induced apoptosis through downregulation of c-FLIP and Bcl-2. Oncol Rep 2012; 28: 1910-1916
    PubMedGoogle Scholar
  • 8 Manda VK, Avula B, Ali Z, Smillie TJ, Khan IA, Khan SI. Characterization of ADME properties of diosgenin and dioscin: bioactive constituents of Dioscorea villosa (Wild yam). International Conference on the Science of Botanicals, Oxford. Planta Med 2013; 79: 79
    PubMedGoogle Scholar
  • 9 Jimenez P, Tejero J, Cabrero P, Cordoba-Diaz D, Girbes T. Differential sensitivity of d-galactose-binding lectins from fruits of dwarf elder (Sambucus ebulus L) to a simulated gastric fluid. Food Chem 2013; 136: 794-802
    CrossrefPubMedGoogle Scholar
  • 10 Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev 2001; 46: 27-43
    CrossrefPubMedGoogle Scholar
  • 11 Smetanova L, Stetinova V, Svoboda Z, Kvetina J. Caco-2 cells, biopharmaceutics classification system (BCS) and biowaiver. Acta Med (Hradec Kralove) 2011; 54: 3-8
    PubMedGoogle Scholar
  • 12 Sun BT, Zheng LH, Bao YL, Yu CL, Wu Y, Meng XY, Li YX. Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells. Eur J Pharmacol 2011; 654: 129-134
    CrossrefPubMedGoogle Scholar
  • 13 Chao P, Uss AS, Cheng KC. Use of intrinsic clearance for prediction of human hepatic clearance. Expert Opin Drug Metab Toxicol 2010; 6: 189-198
    CrossrefPubMedGoogle Scholar
  • 14 FDA. Food and Drug Administration Center for Drug Evaluation and Research. Guidance for industry, waiver of in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms containing certain active moieties/active ingriedients based on biopharmaceutical classification system. Rockville, Maryland, USA: FDA; 2000
    Google Scholar
  • 15 Kuhlmann J, Abshagen U, Rietbrock N. Cleavage of glycosidic bonds of digoxin and derivatives as function of pH and time. Naunyn Schmiedebergs Arch Pharmacol 1973; 276: 149-156
    CrossrefPubMedGoogle Scholar
  • 16 Li K, Tang Y, Fawcett JP, Gu J, Zhong D. Characterization of the pharmacokinetics of dioscin in rat. Steroids 2005; 70: 525-530
    CrossrefPubMedGoogle Scholar
  • 17 Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 1991; 175: 880-885
    CrossrefPubMedGoogle Scholar
  • 18 Dahan A, Miller JM, Hoffman A, Amidon GE, Amidon GL. The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone. J Pharm Sci 2010; 99: 2739-2749
    PubMedGoogle Scholar
  • 19 Loftsson T, Vogensen SB, Brewster ME, Konradsdottir F. Effects of cyclodextrins on drug delivery through biological membranes. J Pharm Sci 2007; 96: 2532-2546
    CrossrefPubMedGoogle Scholar
  • 20 Takahashi Y, Kondo H, Yasuda T, Watanabe T, Kobayashi S, Yokohama S. Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs. Int J Pharm 2002; 246: 85-94
    CrossrefPubMedGoogle Scholar
  • 21 Madgula VL, Avula B, Pawar RS, Shukla YJ, Khan IA, Walker LA, Khan SI. In vitro metabolic stability and intestinal transport of P57AS3 (P57) from Hoodia gordonii and its interaction with drug metabolizing enzymes. Planta Med 2008; 74: 1269-1275
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Madgula VL, Avula B, Choi YW, Pullela SV, Khan IA, Walker LA, Khan SI. Transport of Schisandra chinensis extract and its biologically-active constituents across Caco-2 cell monolayers – an in-vitro model of intestinal transport. J Pharm Pharmacol 2008; 60: 363-370
    CrossrefPubMedGoogle Scholar
  • 23 Makhey VD, Guo A, Norris DA, Hu P, Yan J, Sinko PJ. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm Res 1998; 15: 1160-1167
    CrossrefPubMedGoogle Scholar
  • 24 Sun H, Pang KS. Permeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical study. Drug Metab Dispos 2008; 36: 102-123
    PubMedGoogle Scholar
  • 25 Pang KS, Maeng HJ, Fan J. Interplay of transporters and enzymes in drug and metabolite processing. Mol Pharm 2009; 6: 1734-1755
    CrossrefPubMedGoogle Scholar
  • 26 Taipalensuu J, Tornblom H, Lindberg G, Einarsson C, Sjoqvist F, Melhus H, Garberg P, Sjostrom B, Lundgren B, Artursson P. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 2001; 299: 164-170
    PubMedGoogle Scholar
  • 27 Yamaguchi H, Yano I, Hashimoto Y, Inui KI. Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line caco-2. J Pharmacol Exp Ther 2000; 295: 360-366
    PubMedGoogle Scholar
  • 28 Kobayashi S, Tanabe S, Sugiyama M, Konishi Y. Transepithelial transport of hesperetin and hesperidin in intestinal Caco-2 cell monolayers. Biochim Biophys Acta 2008; 1778: 33-41
    CrossrefPubMedGoogle Scholar
  • 29 Walle UK, French KL, Walgren RA, Walle T. Transport of genistein-7-glucoside by human intestinal CACO-2 cells: potential role for MRP2. Res Commun Mol Pathol Pharmacol 1999; 103: 45-56
    PubMedGoogle Scholar
  • 30 Alvarez-Figueroa MJ, Pessoa-Mahana CD, Palavecino-Gonzalez ME, Mella-Raipan J, Espinosa-Bustos C, Lagos-Munoz ME. Evaluation of the membrane permeability (PAMPA and skin) of benzimidazoles with potential cannabinoid activity and their relation with the Biopharmaceutics Classification System (BCS). AAPS PharmSciTech 2011; 12: 573-578
    CrossrefPubMedGoogle Scholar
  • 31 Li K, Wang Y, Gu J, Chen X, Zhong D. Determination of dioscin in rat plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2005; 817: 271-275
    PubMedGoogle Scholar
  • 32 Tanaka E. Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes. J Clin Pharm Ther 1998; 23: 403-416
    CrossrefPubMedGoogle Scholar
  • 33 Ali Z, Smillie TJ, Khan IA. Cholestane steroid glycosides from the rhizomes of Dioscorea villosa (wild yam). Carbohydr Res 2013; 370: 86-91
    CrossrefPubMedGoogle Scholar
  • 34 USP. United States Pharmacopoeia XXX1/National Formulary 21, USP/NF 2008. Test solutions. Rockville: US Pharmacopeial Convention; 2008: 817
    CrossrefGoogle Scholar
  • 35 Madgula VL, Avula B, Pawar RS, Shukla YJ, Khan IA, Walker LA, Khan SI. Characterization of in vitro pharmacokinetic properties of hoodigogenin A from Hoodia gordonii . Planta Med 2010; 76: 62-69
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Crespi CL, Miller VP, Penman BW. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal Biochem 1997; 248: 188-190
    CrossrefPubMedGoogle Scholar
  • 37 Madgula VL, Avula B, Reddy VLN, Khan IA, Khan SI. Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability. Planta Med 2007; 73: 330-335
    Article in Thieme ConnectPubMedGoogle Scholar